In all patients presenting bilateral adrenal hyperplasia, genetic screening should be offered, including at least the analysis of PRK1R1A in patients with PPNAD and the analysis of ARMC5 in patients with PBMAH. The gene discussed is ARMC5; the disease is primary pigmented nodular adrenocortical disease.